At Mithridates Therapeutics, we isolate peptides from animal toxins (e.g. snake venom, mosquito saliva) and develop them as therapeutic drugs. Through our venom toxin drug discovery platform, we have identified a set of bioactive peptides, which we have sequence-optimized for enhanced target receptor affinity, selectivity and optimal efficacy.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.